Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: The imbalance in the complement system and its possible physiological mechanisms in patients with lung cancer

Fig. 2

Levels of complement components in lung cancer tissues (LC) and paracancerous tissues (PC) from two patients. Lower concentrations of complement components (C3, C4, C5, C4BPA, C4BPB, C6, C7, C9, CFH and CFI) were observed in LC than in PC at the mRNA (a) and protein (b) levels. The mRNA levels of complement components C3, C4, C5, C4BPA, C4BPB, C6, C7, C9, CFH and CFI were decreased 6.4-, 2-, 11-, 8.6-, 64-, 4.5-, 5.5-, 7-, 9- and 13.5-fold in LC, respectively (a). α-Tubulin was used as the loading control (b). Data are presented as the means ± SD (n = 3). *p < 0.05, **p < 0.01

Back to article page